News

What is the European Commission Thinking?

Last week the newly appointed President of the European Commission (EC), Jean-Claude Juncker, decided to not reappoint Anne Glover to Chief Scientific Advisor to the EC and trash the position all together. Critics of Glover did not like how she gave advice to the EC; using facts instead of telling people what they wanted to hear or what was politically popular.

This position was created in…

Genome Compiler – The Platform for Synthetic Biology Tools Welcomes DNA2.0 as a Premium Synthesis Partner

Los Altos, CA and Menlo Park, CA (November 14, 2014). Genome Compiler Corp., a Los Altos based synthetic biology software company entered into a collaborative agreement with DNA2.0, a leading provider of gene synthesis and bioengineering solutions located in Menlo Park, CA. Genome Compiler will be integrating DNA2.0’s gene synthesis services into their design platform, enabling users to design…

DARPA’s New Biotech Funding Program

The Defense Advanced Research Projects Agency (DARPA) has created a simplified grant application process in order to help biotech startups skip the red tape around government grants. DARPA is offering up to $700,000 in seedling funding to businesses operating at the intersection of biology and technology, who would otherwise not pursue government grants due to the long and complicated application…

Bill & Melinda Gates Foundation Helps Launch Vaccine Development Firm

A new vaccine development firm, Affinivax, was recently initiated thanks to funding from the Bill & Melinda Gates Foundation and may receive future funding based on its performance. Affinivax plans on continuing to develop its Multiple Antigen Presenting System (MAPS) and other vaccine development projects with the initial four million dollar investment.

The company will focus on…

De Novo DNA is Joining Genome Compiler’s Suite of Advanced Tools to create Comprehensive Synthetic Biology Solutions

Los Altos, CA and City State, Pennsylvania (September 3, 2014). Genome Compiler Corp., a Los Altos based synthetic biology software company entered into a collaborative agreement with De Novo DNA, a biophysics based genetic software company located in State College, PA. Genome Compiler will be leveraging De Novo DNA’s expertise to further enrich their platform to create a more comprehensiv…

General Mills Debate over GMOs

 

 

General Mills Inc. struck down a proposal to ban GMOs (Genetically Modified Organisms) as ingredients from all their brands last week at their annual shareholder meeting. A resounding 98 percent of shareholders voted against a companywide ban. The definitive decision comes as somewhat of a surprise because of the company’s recent removal of GMOs from its Cheerios cerea…

Igenbio and Genome Compiler Corp. Enter into a Collaborative Agreement to Offer Synthetic Biology Solutions

Chicago, Illinois and Los Altos, CA (Aug 3, 2014). Igenbio. Inc a, Chicago based genome analysis company announced today they entered into a collaborative agreement with Genome Compiler Corp., a Los Altos based synthetic biology software company. Igenbio and Genome Compiler are partnering to create comprehensive synthetic biology solutions. Igenbio Japan will be promoting and distributing its…

Leading Scientists Address Congress on Future of Synthetic Biology

Dr. Karmella Haynes, an assistant professor from Arizona State University, was among a small group of scientists who addressed a recent Congressional hearing about the emerging field of Synthetic Biology. In the Haynes Lab at the ASU School of Biological and Health Systems Engineering, Dr. Haynes is currently involved in synthetic biology research in the hopes of solving some of the world’s…

Playing the China Card with Genetic Testing

The Chinese Food and Drug Administration have just opened a huge new market for a revolutionary, essentially risk-free prenatal test for the three most common genetic diseases. The NIFTY test, designed by the Beijing Genomics Institute, is a simple, highly accurate, and non-invasive test that is now available to millions of Chinese women.
 The NIFTY test requires a mere 10ml of a mother’s…

Debug your project with a single click. Compilation Design Rules Engine now streamlines common and synthesizer specific design rules.

Genome Compiler’s new Compilation Design Rules Engine allows for users to now ensure that their projects follow nature’s engineering constraints as well specific rules from the industry’s most prominent synthesizers. Also look forward for future releases to establish your own design constraints as well. Debugging complex synthetic biology work has never been easier.
Features such as t…

Copyright © Genome Compiler 2014. All Rights Reserved.